Pulmonx Corporation
LUNG
$7.05
-$0.27-3.69%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 23.28% | 15.39% | 20.87% | 29.71% | 24.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.28% | 15.39% | 20.87% | 29.71% | 24.98% |
| Cost of Revenue | 26.59% | 15.56% | 22.78% | 21.03% | 15.02% |
| Gross Profit | 22.15% | 15.33% | 20.21% | 32.95% | 28.76% |
| SG&A Expenses | 10.58% | 5.95% | 7.89% | 7.34% | 11.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.00% | 5.09% | 8.24% | 7.94% | 10.47% |
| Operating Income | 3.61% | 6.90% | 4.97% | 11.37% | 4.84% |
| Income Before Tax | 3.69% | 5.99% | 5.06% | 13.81% | 2.83% |
| Income Tax Expenses | -84.68% | 225.42% | -40.00% | 50.00% | 0.81% |
| Earnings from Continuing Operations | 5.13% | 5.07% | 5.37% | 13.31% | 2.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.13% | 5.07% | 5.37% | 13.31% | 2.77% |
| EBIT | 3.61% | 6.90% | 4.97% | 11.37% | 4.84% |
| EBITDA | 3.73% | 6.99% | 10.03% | 11.59% | 4.28% |
| EPS Basic | 8.01% | 7.88% | 8.10% | 15.68% | 5.29% |
| Normalized Basic EPS | 6.62% | 8.75% | 7.80% | 16.20% | 5.37% |
| EPS Diluted | 8.01% | 7.88% | 8.10% | 15.68% | 5.29% |
| Normalized Diluted EPS | 6.62% | 8.75% | 7.80% | 16.20% | 5.37% |
| Average Basic Shares Outstanding | 3.14% | 3.03% | 2.97% | 2.83% | 2.67% |
| Average Diluted Shares Outstanding | 3.14% | 3.03% | 2.97% | 2.83% | 2.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
